Literature DB >> 19164394

High doses of deferiprone may be associated with cerebellar syndrome.

F Beau-Salinas1, M A Guitteny, J Donadieu, A P Jonville-Bera, E Autret-Leca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19164394     DOI： 10.1136/bmj.a2319

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Iron-chelating therapy for transfusional iron overload.

Authors:  Gary M Brittenham
Journal:  N Engl J Med       Date:  2011-01-13       Impact factor: 91.245

2.  Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia.

Authors:  Saumya S Jamuar; Angeline H M Lai
Journal:  Ther Adv Hematol       Date:  2012-10

Review 3.  Management of the thalassemias.

Authors:  Nancy F Olivieri; Gary M Brittenham
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

Review 4.  From Rust to Quantum Biology: The Role of Iron in Retina Physiopathology.

Authors:  Emilie Picard; Alejandra Daruich; Jenny Youale; Yves Courtois; Francine Behar-Cohen
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.